Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
Kaya, A.H., Tekgunduz, E., Akpinar, S., Batgi, H., Bekdemir, F., Kayikci, O., Namdaroglu, S., Ulu, B.U., Dal, M.S., Cakar, M.K., Korkmaz, S., Altuntas, F.
Published in Transplantation proceedings (01.10.2017)
Published in Transplantation proceedings (01.10.2017)
Get full text
Journal Article